The content on this site is intended for healthcare professionals only
Dr Punnen talks to ecancertv at ASCO GU 2015 about prostate screening and risk assessment - should people receive treatment when they wouldn't live long enough to be affected by their cancer? Should they even be biopsied in the first place?
ESMO 2024: Optimising the personalisation of prostate cancer treatment
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Management of prostate cancer in Africa: Looking to the future
Choosing Wisely in radiology Tanzania
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality
